YING YUAN to Adenocarcinoma
This is a "connection" page, showing publications YING YUAN has written about Adenocarcinoma.
Connection Strength
0.093
-
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol. 2023 Dec; 24(12):1387-1398.
Score: 0.064
-
Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets. PLoS One. 2012; 7(9):e45894.
Score: 0.029